Galectin Therapeutics Inc.
Price Action
Technical Summary
WEAKENINGGalectin Therapeutics Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 93), indicating clear outperformance against the broad market. Earnings growth of 49% provides fundamental context to the price action. However, with RSI at 85, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.85 | +75.11% | ABOVE |
| 50 SMA | $2.53 | +96.99% | ABOVE |
| 100 SMA | $2.69 | +85.62% | ABOVE |
| 150 SMA | $3.28 | +52.00% | ABOVE |
| 200 SMA | $3.72 | +33.97% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is GALT in an uptrend right now?
GALT has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is GALT overbought or oversold?
GALT's RSI (14) is 85. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is GALT outperforming the market?
GALT has a Relative Strength (RS) Rating of 93 out of 99. Yes, GALT is a market leader, outperforming 93% of all stocks over the past 12 months.
Where is GALT in its 52-week range?
GALT is trading at $4.99, which is 70% of its 52-week high ($7.13) and 58% above its 52-week low ($2.02).
How volatile is GALT?
GALT has a Beta of 1.01 and 52-week volatility of 91%. It's more volatile than the S&P 500 - expect bigger swings.